In a 24-week randomized placebo-controlled trial, volunteers with elevated uric acid levels who received twice-daily capsules of 500 mg T. bellerica extract demonstrated a notable 9.8% average decrease in uric acid levels after only 4 weeks. At the end of the study, uric acid levels were reduced by a remarkable 28.4%, with no reported adverse side effects. This decrease in uric acid levels enabled 89% of the participants who were taking the extract to achieve targeted uric acid serum levels. Further, evidence from pre-clinical studies suggest that the bioactive compounds in T. bellerica may also help support a healthy response to inflammatory factors and has antioxidant properties.
Ayuric Terminalia bellerica extract (fruit) [std. to 15% tannins] 500 mg Other ingredients: vegetable cellulose (capsule), microcrystalline cellulose, stearic acid, silica.
- No classifications for this product